Anti-inflammatory nutraceuticals and herbal medicines for the management of metabolic syndrome

George Q. Li*, Ka H. Wong, Antony Kam, Xian Zhou, E. Omar, A. Algahtani, Kong M. Li, V. Razmovski-Naumovski, Kelvin Chan

*Corresponding author for this work

Research output: Chapter in Book or Report/Conference proceedingChapterpeer-review


Metabolic syndrome, previously known as syndrome X and insulin resistance syndrome, refers to a constellation of disorders including central obesity, insulin resistance, glucose intolerance, dyslipidemia, and hypertension. These risk factors have been linked to an increased probability of cardiovascular diseases and type 2 diabetes mellitus. The World Health Organization (WHO) estimates that by 2015, approximately 2.3 billion adults worldwide will be overweight, and more than 700 million adults will be obese (WHO 2006). Additionally, the global prevalence of type 2 diabetes will rise to 336 million by 2030 (International Diabetes Foundation 2009).
Original languageEnglish
Title of host publicationChronic Inflammation
PublisherCRC Press
ISBN (Electronic)9780429109874
Publication statusPublished - 2012


Dive into the research topics of 'Anti-inflammatory nutraceuticals and herbal medicines for the management of metabolic syndrome'. Together they form a unique fingerprint.

Cite this